01 1Zhejiang better Pharmaceutical
01 1CLARITHROMYCIN USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-11-29
Pay. Date : 2018-07-12
DMF Number : 20501
Submission : 2007-04-30
Status : Active
Type : II
20
Zhejiang Better Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CLARITHROMYCIN USP, with a corresponding US DMF Number 20501.
Remarkably, this DMF maintains an Active status since its submission on April 30, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 29, 2018, and payment made on July 12, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
